Antagonists of the bradykinin B1 receptor
US8278280B2 · kind B2 · utility
0Cited by
19References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2008 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Jun 2, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to composition of matter involving bradykinin B1 receptor antagonist peptides conjugated to a multivalent vehicle, including peptides conjugated to multivalent PEG. These compositions can be used as therapeutics or prophylactics against diseases or conditions, such as inflammation or pain, linked to the bradykinin B1 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.